Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-AnalysisSARS-CoV-2 및 인플루엔자와의 동시 감염이 질병 중증도에 미치는 영향: 체계적인 검토 및 메타 분석Review Published on 2021-12-102022-09-11 Journal: Frontiers in Public Health [Category] SARS, 치료기술, [키워드] aPTT article association calculate China CNKI Cochrane Library Coinfection COVID-19 patient COVID-19 patients Critical disease disease severity Effect evaluate fixed had no identify Impact indicated Infection influence Influenza influenza strain influenza vaccination Infrastructure Laboratory lower risk lymphocyte Lymphocyte count lymphocyte counts material Meta-analysis Mortality no effect outcome overall mortality Patient random effect Region Result review risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection searched significantly significantly increased simultaneously infected the disease vaccination virus viruses Web of Science [DOI] 10.3389/fpubh.2021.773130 PMC 바로가기 [Article Type] Review
Epidemiological features of COVID-19 patients with prolonged incubation period and its implications for controlling the epidemics in ChinaResearch Published on 2021-12-092022-10-28 Journal: BMC Public Health [Category] COVID-19, SARS, [키워드] accelerated adjusted administration analyzed association China clinical feature Clinical practice Clinical severity COVID-19 COVID-19 case COVID-19 patient determinant disease onset elderly patients Epidemics epidemiological Evidence exceeded extreme feature implication Incubation period Level Local lower risk measure Patient Poisson regression model Prolonged incubation period provide quarantine reduced remained reported Result SARS-CoV-2 South supplementary material Transmissibility were used [DOI] 10.1186/s12889-021-12337-9 PMC 바로가기 [Article Type] Research
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD studyObservational Study Published on 2021-12-012022-10-05 Journal: Alimentary pharmacology & therapeutics [Category] SARS, 임상, [키워드] Active disease adverse outcome adverse outcomes age anti-TNF Asymptomatic build cohort study Comorbidity Course COVID-19 COVID-19 in patient death disease evaluated General population greater help higher risk hospitalisation IBD identify Immune-mediated Inflammatory bowel disease inflammatory disease lower risk medication moderate multivariable analyses multivariable logistic regression obesity outcome outcomes Patient patients Pneumonia risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection severe COVID-19 significantly therapy ulcerative colitis ventilatory support was used [DOI] 10.1111/apt.16663 PMC 바로가기 [Article Type] Observational Study
Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort studyResearch article Published on 2021-12-012022-10-05 Journal: The Lancet Regional Health - Americas [Category] 변종, [키워드] 95% CI accounting Analysis average age Breakthrough infection Care center clinical variable cohort analysis Comorbidity Control coronavirus COVID-19 demographic determine diagnosed with COVID-19 disease Efficacy Elderly patient Endpoint female finding group groups hospital ICU improvement In-hospital death individuals Infection intensive care unit less lower risk mechanical ventilation Mortality multicenter cohort study occur outcome Patient patients patients with SARS-CoV-2 peaked preventing infection reduce Region registry remained required SARS-CoV-2 secondary shown statistically the SARS-CoV-2 Treatment vaccinated individual vaccination Vaccine variant variants viral strains was obtained while [DOI] 10.1016/j.lana.2021.100065 [Article Type] Research article
DrugWAS: Drug-wide Association Studies for COVID-19 Drug RepurposingDrugWAS: COVID-19 약물 용도 변경에 대한 약물 전반의 협회 연구Article Published on 2021-12-012022-09-11 Journal: Clinical Pharmacology and Therapeutics [Category] MERS, 신약개발, [키워드] 95% CI 95% confidence interval Admission Analysis applied association azelastine center clinical trials cohort study coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 diagnosis COVID-19 disease COVID-19 severity death Dextromethorphan diphtheria toxoid drug drugs Efficacy EHR EHR data Electronic health record estradiol ethinyl estradiol exposure to fatty acids Flaxseed fluticasone Health health record ibuprofen identify IMPROVE intensive care intensive care unit list lower risk mechanical ventilation multivariable logistic regression Odds ratio omega-3 Omega-3 fatty acids outcomes overlap pandemic patients with COVID-19 performed pertussis vaccine pneumococcal polysaccharide vaccine Potential treatment Primary outcome Propensity score pseudoephedrine randomized clinical trial repurposing retrospective cohort risk of death secondary Secondary analyses Secondary outcomes significantly tetanus toxoid ubidecarenone university Vaccine Vaccines was selected Weighting [DOI] 10.1002/cpt.2376 PMC 바로가기 [Article Type] Article
Pediatric COVID-19 Therapeutics Seizing the Right Research and Development Opportunities to Accelerate Access for Children소아 코비드 19 치료제 어린이의 접근을 가속화 할 수있는 올바른 연구 및 개발 기회를 포착Commentary Published on 2021-11-262022-09-10 Journal: The Pediatric Infectious Disease Journal [Category] SARS, 신약개발, [키워드] accelerate Accelerator access Adults benefit children COVID-19 development lower risk opportunity outcome pediatric pediatrics Perspective Prognosis Research research and development right SARS-CoV-2 therapeutic therapeutic interventions therapeutic trials Therapeutics Trial understanding [DOI] 10.1097/INF.0000000000003331 PMC 바로가기 [Article Type] Commentary
Anticoagulation treatment for patients with coronavirus disease 2019 (COVID-19) and its clinical effectiveness in 2020 A meta-analysis study4900 Published on 2021-11-242022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] 95% confidence interval Anticoagulant treatment anticoagulation articles bleeding CBM Chinese clinical effectiveness CNKI Cochrane Library contrary coronavirus disease COVID-19 effective effort Google Scholar Healthcare provider lower risk Meta-analysis Methodological quality Mortality no significant difference occurred outbreak Patient patients Prophylactic public health Publication bia random-effects model reducing mortality risk searched therapeutic anticoagulation thrombosis treat Treatment VIP was used Web of Science [DOI] 10.1097/MD.0000000000027861 PMC 바로가기 [Article Type] 4900
A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid MalignancyConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 유전자 메커니즘, [키워드] adaptive addition adjusted age Analysis anti-CD20 Antibody testing anticancer association cancer patient CCI center Characteristics Charlson Comorbidity Index Chemotherapy Clinical characteristics CLL Cohort Comorbidity Complete covariate COVID-19 COVID-19 diagnosis current death Descriptive statistics Diagnosis disease download Effect EMR endpoints equity estimate evaluate event events female figure Final funding Genentech General population Hematologic malignancy high risk higher risk Hoffmann-La Roche Hospital admission humoral immune response Humoral immunity immune defects increased risk indolent Interaction interaction effect Kite lower risk lymphoid lymphoma male malignancies malignancy median monoclonal antibody Mortality Multivariate analysis NHL nucleocapsid Odds ratio outcome outcomes P-value Patient patients positive result Previous studies Prophylaxis Regression model response to vaccination retrospective review risk risk factor SARS-CoV-2 SARS-CoV-2 PCR Seattle Sharp shown speaker statistically significant suggested table therapy USA variable was used were used while with COVID-19 [DOI] 10.1182/blood-2021-146398 [Article Type] Conference abstract
Was the risk of death among the population of teachers and other school workers in England and Wales due to COVID-19 and all causes higher than other occupations during the pandemic in 2020? An ecological study using routinely collected data on deaths from the Office for National StatisticsEpidemiology Published on 2021-11-232022-10-28 Journal: BMJ Open [Category] COVID-19, Fulltext, MERS, SARS, [키워드] age all-cause mortality assistant available data average cause collected data correlation COVID-19 COVID-19 mortality COVID-19 pandemic death ecological England Evidence female groups higher risk Infectious diseases lower risk male men Mortality mortality rate mortality risk National Non-COVID-19 objective occupational & industrial medicine office pandemic participant Primary outcome professionals Result risk risk of death School secondary outcome setting Statistics Teaching with COVID-19 [DOI] 10.1136/bmjopen-2021-050656 PMC 바로가기 [Article Type] Epidemiology
Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory ProfilesArticle Published on 2021-11-202022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] ABO Admission analyzed AUC Biomarker Blood Group characteristic clinical Clinical data clinical variable collected Comorbidity conducted COVID-19 COVID-19 patient COVID-19 patients cytokine cytokine profile Cytokines death Diagnosis hepatocyte growth factor HGF Hospital admission identify intubation Laboratory lower risk modeling Other outcome Patient plasma Poor predict Predictive profile risk robust ROC sensitivity serum cytokine Spain specificity validation were measured [DOI] 10.3390/jcm10225431 PMC 바로가기 [Article Type] Article